Listan, a leading provider of high-performance computer components, has been acquired by Afinum
The three founders of Listan GmbH have sold a majority stake in the company to Afinum.
Listan, through its brands “be quiet!” and “Xilence”, provides high-performance PC components targeted at performance gamers and computer enthusiasts. Based on products with superior features such as extremely low noise and heat emission levels, industry-leading product quality and award-winning design, the company has gained trust and brand awareness among its relevant distribution channels and its end customers. Since its foundation in 2000, Listan has become one of the market leaders in the DACH region and has successfully initiated its geographical expansion in Europe and globally.
Afinum is an independent investment firm owned by its management team, with offices in Munich, Zurich and Hong Kong, specializing in the acquisition of shareholdings in financially sound and successful mid-market companies in the German speaking region as well as in neighboring countries in Europe.
Throughout the whole process, Oaklins’ team in Germany acted as the lead advisor to the three founders of Listan. Oaklins advised in the preparation of the sale process and due diligence as well as the approach and parallel negotiations with potential financial investors until closing.
Talk to the deal team
Dr. Hans Bethge
Senior AdvisorHamburg, Germany
Associate DirectorHamburg, Germany
Alexander G.W. Choy
Senior AssociateHamburg, Germany
VHZ Group has been acquired by Gilde Equity Management and VHZ Group’s management
VHZ Group, the market leader in the Dutch B2B uPVC windows and doors market, has been acquired by Gilde Equity Management (GEM) together with the company’s management. With the acquisition, VHZ Group and GEM will be able to further expand on the company’s strategy and vision.Learn more
ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners
Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.Learn more
esignatur has been acquired by Scrive
esignatur has been acquired by Scrive, a portfolio company of Vitruvian Partners. esignatur and Scrive both specialize in digital signing solutions and complement each other with strong geographical and sector reach.Learn more